Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Phase II Study of Nivolumab in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma

NCT02339558 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02339558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02339558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Phase II Study of Nivolumab in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
July 21, 2015
Completion date
Not reported
Enrollment
45 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal nonkeratinizing carcinoma, recurrent nasopharynx carcinoma, stage iii nasopharyngeal carcinoma ajcc v7, stage iv nasopharyngeal carcinoma ajcc v7, stage iva nasopharyngeal carcinoma ajcc v7, stage ivb nasopharyngeal carcinoma ajcc v7, stage ivc nasopharyngeal carcinoma ajcc v7